Home
About
Contact
About Me
Heal Research
Home
Features
_Multi DropDown
__DropDown 1
__DropDown 2
__DropDown 3
_ShortCodes
_SiteMap
_Error Page
Mega Menu
Documentation
_Web Documentation
_Video Documentation
Home
News Medical Medical Research News Feed
No benefit of low dose apixaban following acute COVID-19
No benefit of low dose apixaban following acute COVID-19
Preetam Gupta
18:17
The HEAL-COVID trial compared the efficacy of Apixaban to standard care in adults who have recently recovered from severe COVID-19.
from News Medical Medical Research News Feed https://ift.tt/DvyZSYT
Post a Comment
0 Comments
Social Plugin
Popular Posts
Mosquito excrement offers new way to detect circulating viruses
11:04
Why might a higher BMI at 20 be linked to lower breast cancer risk later in life?
21:04
‘Fully compliant’: Nestlé India responds to FSSAI action over infant nutrition products
20:39
Technology
3/Technology/post-list
Categories
Tags
0 Comments